Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors

por Noda, Mami, Kobayashi, AI
Publicado 2016

Correction to: Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors

por Noda, Mami, Kobayashi, AI
Publicado 2018

The seasonal variations of allelopathic activity and allelopathic substances in Brachiaria brizantha

por Kobayashi, Ai, Kato-Noguchi, Hisashi
Publicado 2015

A case report of coronavirus disease‐2019‐induced acute asthma exacerbation in an obese patient

por Sasaki, Hisashi, Miyata, Jun, Kobayashi, Ai, Kawano, Shuichi, Kawana, Akihiko
Publicado 2022

Lung cancer: a 6-field technique using lateral beams in conformal radiotherapy for bilateral supraclavicular lymph node metastases

por Tsutsumi, Shinichi, Tada, Takuhito, Maekado, Tomoko, Tokunaga, Masahiro, Tanaka, Noriko, Kobayashi, Ai, Okazaki, Eiichiro, Matsuda, Shougo, Hosono, Masako N, Miki, Yukio
Publicado 2014

Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome

por Melamed, Isaac, Kobayashi, Roger H., O'Connor, Maeve, Kobayashi, Ai Lan, Schechterman, Andrew, Heffron, Melinda, Canterberry, Sharon, Miranda, Holly, Rashid, Nazia
Publicado 2021

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects...

por Wasserman, Richard L., Lumry, William, Harris, James, Levy, Robyn, Stein, Mark, Forbes, Lisa, Cunningham-Rundles, Charlotte, Melamed, Isaac, Kobayashi, Ai Lan, Du, Wei, Kobayashi, Roger
Publicado 2016

Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies

por Kobayashi, Roger H., Gupta, Sudhir, Melamed, Isaac, Mandujano, J. Fernando, Kobayashi, Ai Lan, Ritchie, Bruce, Geng, Bob, Atkinson, Thomas Prescott, Rehman, Syed, Turpel-Kantor, Eva, Litzman, Jiří
Publicado 2019

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig(®)]) in the treatment of patients with primary immunodeficien...

por Kobayashi, Roger H., Gupta, Sudhir, Melamed, Isaac, Mandujano, J. Fernando, Kobayashi, Ai Lan, Ritchie, Bruce, Geng, Bob, Atkinson, Thomas Prescott, Rehman, Syed, Turpel-Kantor, Eva, Litzman, Jiří
Publicado 2022

Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

por Borte, Michael, Melamed, Isaac R., Pulka, Grazyna, Pyringer, Barbara, Knutsen, Alan P., Ochs, Hans D., Kobayashi, Roger H., Kobayashi, Ai Lan, Gupta, Sudhir, Strach, Magdalena, Smits, William, Pituch-Noworolska, Anna, Moy, James N.
Publicado 2017

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig(®)) in the treatment of patients with primary immunodeficiencies

por Kobayashi, Roger H, Litzman, Jiří, Melamed, Isaac, Mandujano, J Fernando, Kobayashi, Ai Lan, Ritchie, Bruce, Geng, Bob, Atkinson, T Prescott, Rehman, Syed, Höller, Sonja, Turpel-Kantor, Eva, Kreuwel, Huub, Speer, J C, Gupta, Sudhir
Publicado 2022

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens

por Gupta, Sudhir, DeAngelo, James, Melamed, Isaac, Walter, Jolan E., Kobayashi, Ai-Lan, Bridges, Tracy, Sublett, J. Wesley, Bernstein, Jonathan A., Koterba, Alan, Manning, Michael, Maltese, Joanna, Hoeller, Sonja, Turpel-Kantor, Eva, Kreuwel, Huub, Kobayashi, Roger H.
Publicado 2023